Risdiplam
Risdiplam, sold under the brand name Evrysdi, is a medication used to treat spinal muscular atrophy (SMA) and the first oral medication approved to treat this disease. Risdiplam is a survival of motor neuron 2-directed RNA splicing modifier. In clinical trials, the most common adverse events included fever, diarrhea, rash, ulcers of the mouth area, joint pain (arthralgia) and urinary tract infections. Additional adverse events observed in the infantile-onset population included upper respiratory tract infection, pneumonia, constipation and vomiting.
medication
Link from a Wikipage to another Wikipage
medication
primaryTopic
Risdiplam
Risdiplam, sold under the brand name Evrysdi, is a medication used to treat spinal muscular atrophy (SMA) and the first oral medication approved to treat this disease. Risdiplam is a survival of motor neuron 2-directed RNA splicing modifier. In clinical trials, the most common adverse events included fever, diarrhea, rash, ulcers of the mouth area, joint pain (arthralgia) and urinary tract infections. Additional adverse events observed in the infantile-onset population included upper respiratory tract infection, pneumonia, constipation and vomiting.
has abstract
Risdiplam, sold under the bran ...... entech, a subsidiary of Roche.
@en
alternative name
Evrysdi
@en
CAS number
1825352-65-5
ChEMBL
DrugBank
FDA UNII code
76RS4S2ET1
KEGG
PubChem
Link from a Wikipage to an external page
Wikipage page ID
55,481,518
page length (characters) of wiki page
Wikipage revision ID
1,014,007,462
Link from a Wikipage to another Wikipage
ATC prefix
M09
@en
ATC suffix
AX10
@en
CAS number
ChEMBL
ChemSpiderID
67,886,354
DailyMedID
Risdiplam
@en
DrugBank
DB15305
@en
IUPAC name
KEGG
D11406
@en
legal US
Rx-only
@en
PubChem
118,513,932
routes of administration
SMILES
CC1=CCC3=CCN4C=CN5CCNC6CC6
@en
StdInChIKey
ASKZRYGFUPSJPN-UHFFFAOYSA-N
@en
synonyms
RG7916; RO7034067
@en
tradename
Evrysdi
@en
wikiPageUsesTemplate
comment
Risdiplam, sold under the bran ...... ia, constipation and vomiting.
@en
label
Risdiplam
@en